“…1,7,35 Additionally, S-nitrosoglutathione (GSNO) metabo- determinant of asthmatic airway acidifi cation. 18,42,43 Therefore, the subset of patients with increased GSNO reductase activity might be predicted to have low F e NO and low EBC pH. One way or another, this subset appears to be biochemically unique and may be a subset in which the metabolomically targeted therapy (for example, with inhaled base 7,35 ) may be particularly benefi cial.…”